RecruitingNCT05889741
Stellate ganglion block or sham injection alongside prolonged exposure for PTSD
About this title
Read the official source — NCT05889741Medication studyAges 18–65United States
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Fort Hood and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 26, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 140
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05889741
- Official title
Show the full official title
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD: A Randomized Clinical Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Fort Hood · San Antonio
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center at San Antonio, a university.
Does this study involve medication?
Yes. The study involves medication, including Ropivacaine injection and Normal saline.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
